Alzamend Neuro Inc expected to post a loss of 4 cents a share - Earnings Preview

Alzamend Neuro

11/09/2023 21:02

* Alzamend Neuro Inc  ALZN.OQ   ALZN.O  is expected to show
no
change in quarterly revenue when it reports  results on
September 13 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Alzamend Neuro Inc
is for
a loss of 4 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Alzamend
Neuro
Inc is $3.88​, above​ its last closing price of $0.24. ​​​

This summary was machine generated September 11 at 20:02 GMT. 
All figures in US dollars  unless otherwise stated